Archives
-
Separating Growth Inhibition from Cancer Cell Death
2026-08-17
Hannah Schwartz’s dissertation examines why relative viability and fractional viability should not be treated as interchangeable measures of anticancer drug response. Its central contribution is a framework for distinguishing proliferative arrest from true cell killing, improving interpretation of in vitro experiments and the design of translational cancer models.
-
2-Hydroxypropyl-β-cyclodextrin Protocol Guide
2026-08-16
2-Hydroxypropyl-β-cyclodextrin is a water-soluble cyclic oligosaccharide used to improve the apparent aqueous solubility of poorly soluble hydrophobic compounds, particularly molecules containing aromatic or phenyl groups. It is appropriate for validated pharmaceutical and biochemical solubility workflows, but should not be treated as evidence of clinical efficacy, universal bioavailability improvement, or suitability for applications outside the documented excipient and solubilization scope.
-
YAP-TEAD Control of Surface Ectoderm Super-Enhancers
2026-08-15
The reference study maps how super-enhancers and three-dimensional chromatin contacts coordinate early surface ectoderm commitment from pluripotent stem cells. Its functional experiments identify YAP-TEAD, particularly TEAD activity, as an upstream regulator that promotes early super-enhancer establishment and activation of lineage-associated genes.
-
Stat3 Links Fyn to Zebrafish Neurodegeneration
2026-08-14
Siddiqui and colleagues used a neural-specific zebrafish model of constitutively active Fyn to connect dopaminergic neuron loss with microglial inflammation. Their imaging, transcriptomic, and pharmacological data identify Stat3 as a downstream Fyn effector that cooperates with NF-κB, providing a mechanistic framework for future functional gene studies in neurodegeneration.
-
EZ Cap EGFP mRNA 5-moUTP: Assay Guide
2026-08-14
Build more reliable reporter, delivery, and translation workflows with a Cap1-, 5-moU-modified EGFP transcript. This practical guide connects routine cell assays with tissue-delivery studies while separating product-supported specifications from optimization starting points.
-
HyperScribe Co-transcription mRNA Synthesis Kit Plus
2026-08-13
The HyperScribe Co-transcription mRNA Synthesis Kit Plus combines T7-driven transcription with ARCA capping and template-encoded polyadenylation for translation-ready RNA. Its most useful applications range from rapid reporter and in vitro translation assay development to more demanding RNA vaccine and nanovaccine workflows.
-
Engineering mRNA for Spleen-Targeted Vaccines
2026-08-13
Spleen-targeted neoantigen vaccination highlights a central translational lesson: delivery biology cannot compensate for poorly engineered RNA. This article connects ARCA capping, 5mCTP, ψUTP incorporation, DNA removal, and poly(A) tailing with the immune mechanisms reported in hepatocellular carcinoma, while outlining how researchers can build more reproducible mRNA workflows.
-
Dynamically Covalent LNPs for CRISPR CNV Therapy
2026-08-12
Cao and colleagues developed dynamically covalent lipid nanoparticles that deliver Cas9 mRNA and VEGFA-targeting guide RNA for transient genome editing in a mouse model of choroidal neovascularization. Their iminoboronate-containing lipidoid design links disease-responsive particle disassembly with improved intracellular RNA release, producing sustained VEGFA disruption after a single intravitreal treatment.
-
Pazopanib (GW-786034) in Cancer Research
2026-08-12
Pazopanib (GW-786034) combines VEGFR, PDGFR, and FGFR pathway coverage with a practical workflow for studying angiogenesis, receptor tyrosine kinase signaling, and genotype-dependent drug response. This guide translates findings from ATRX-deficient glioma research into dose design, phospho-signaling assays, viability studies, and troubleshooting strategies.
-
Recombinant Human Growth Hormone Assay Logic
2026-08-11
Recombinant Human Growth Hormone can do more than stimulate a growth readout: it can serve as a controlled perturbation for testing receptor, IGF-1, IGFBP2, and THBS1 relationships. This article translates recent chondrocyte findings into a rigorous framework for interpreting growth hormone signaling experiments.
-
3-Aminobenzamide: A Translational PARP Strategy
2026-08-11
A mechanistic and strategic guide to using 3-Aminobenzamide (PARP-IN-1) across oxidative-stress, vascular, renal, and innate-immunity models—while distinguishing useful pathway interrogation from claims of therapeutic efficacy.
-
DMG-PEG2000-NH2: LNP Workflow & Troubleshooting
2026-08-10
DMG-PEG2000-NH2 combines a primary amine with a PEG spacer and lipid-compatible architecture for practical conjugation and lipid nanoparticle formulation. This guide translates its chemistry into reproducible workflows for liposomes, siRNA encapsulation, assay design, and troubleshooting while keeping delivery claims separate from antimycobacterial evidence.
-
rhBNP, Selenium Recycling, and Renal Ferroptosis
2026-08-09
The reference study identifies selenocysteine lyase 1 (SCLY)-dependent selenium recycling as a central mechanism by which recombinant human brain natriuretic peptide (rhBNP) limits ferroptosis during renal ischemia-reperfusion injury. Evidence from ICU patients, rat models, transcriptomics, and HK2-cell perturbation experiments supports SCLY as a potential mechanistic and therapeutic target in acute kidney injury.
-
BHA Workflows for Oxidative Stress Research
2026-08-08
Build reproducible Butylated hydroxyanisole workflows for ROS detection, cellular protection, and mechanism-oriented stress assays. This guide emphasizes solvent controls, time-resolved dosing, orthogonal validation, and troubleshooting so BHA separates antioxidant effects from assay artifacts.
-
HyperScribe All in One mRNA Synthesis Kit Plus 1 Guide
2026-08-07
Build capped, modified, and polyadenylated transcripts in a single T7-based workflow for translation, RNA vaccine development, and RNAi research. The kit combines ARCA capping, 5mCTP, ψUTP, DNase treatment, and enzymatic poly(A) tailing to reduce workflow complexity and support reproducible mRNA design.